# Vitamin D Supplementation in Polymorphic Light Eruption

> **NCT01595893** · PHASE3 · TERMINATED · sponsor: **Medical University of Graz** · enrollment: 8 (actual)

## Conditions studied

- Polymorphic Light Eruption

## Interventions

- **DRUG:** Oral Vitamin D 3
- **DRUG:** Miglyol 812 N

## Key facts

- **NCT ID:** NCT01595893
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-04
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Difficulties in recruiting the planned number of patients
- **Last updated:** 2016-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01595893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01595893, "Vitamin D Supplementation in Polymorphic Light Eruption". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01595893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*